BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34287940)

  • 1. Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps.
    Wang H; Xue J; Qu T; Bernstein K; Chen T; Barbee D; Silverman JS; Kondziolka D
    Med Phys; 2021 Sep; 48(9):5522-5530. PubMed ID: 34287940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery.
    Mouraviev A; Detsky J; Sahgal A; Ruschin M; Lee YK; Karam I; Heyn C; Stanisz GJ; Martel AL
    Neuro Oncol; 2020 Jun; 22(6):797-805. PubMed ID: 31956919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
    Zhang Z; Yang J; Ho A; Jiang W; Logan J; Wang X; Brown PD; McGovern SL; Guha-Thakurta N; Ferguson SD; Fave X; Zhang L; Mackin D; Court LE; Li J
    Eur Radiol; 2018 Jun; 28(6):2255-2263. PubMed ID: 29178031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.
    Huang CY; Lee CC; Yang HC; Lin CJ; Wu HM; Chung WY; Shiau CY; Guo WY; Pan DH; Peng SJ
    J Neurooncol; 2020 Feb; 146(3):439-449. PubMed ID: 32020474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases.
    Basree MM; Li C; Um H; Bui AH; Liu M; Ahmed A; Tiwari P; McMillan AB; Baschnagel AM
    J Neurooncol; 2024 Jun; 168(2):307-316. PubMed ID: 38689115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics.
    Peng L; Parekh V; Huang P; Lin DD; Sheikh K; Baker B; Kirschbaum T; Silvestri F; Son J; Robinson A; Huang E; Ames H; Grimm J; Chen L; Shen C; Soike M; McTyre E; Redmond K; Lim M; Lee J; Jacobs MA; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1236-1243. PubMed ID: 30353872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment Spatially Aware Magnetic Resonance Imaging Radiomics Can Predict Distant Brain Metastases (DBMs) After Stereotactic Radiosurgery/Radiation Therapy (SRS/SRT).
    Bae J; Mani K; Zabrocka E; Cattell R; O'Grady B; Payne D; Roberson J; Ryu S; Prasanna P
    Adv Radiat Oncol; 2024 May; 9(5):101457. PubMed ID: 38550363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: A pilot study.
    Simpson G; Spieler B; Dogan N; Portelance L; Mellon EA; Kwon D; Ford JC; Yang F
    Med Phys; 2020 Aug; 47(8):3682-3690. PubMed ID: 32329904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Response to Stereotactic Radiosurgery for Brain Metastases Using Convolutional Neural Networks.
    Cha YJ; Jang WI; Kim MS; Yoo HJ; Paik EK; Jeong HK; Youn SM
    Anticancer Res; 2018 Sep; 38(9):5437-5445. PubMed ID: 30194200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.
    Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S
    J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to gamma knife radiosurgery.
    Jiang Z; Wang B; Han X; Zhao P; Gao M; Zhang Y; Wei P; Lan C; Liu Y; Li D
    Eur Radiol; 2022 Apr; 32(4):2266-2276. PubMed ID: 34978579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning.
    Jaberipour M; Soliman H; Sahgal A; Sadeghi-Naini A
    Sci Rep; 2021 Nov; 11(1):21620. PubMed ID: 34732781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases.
    Gutsche R; Lohmann P; Hoevels M; Ruess D; Galldiks N; Visser-Vandewalle V; Treuer H; Ruge M; Kocher M
    Radiother Oncol; 2022 Jan; 166():37-43. PubMed ID: 34801629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG PET/MRI Coregistration Helps Predict Response to Gamma Knife Radiosurgery in Patients With Brain Metastases.
    Leiva-Salinas C; Muttikkal TJE; Flors L; Puig J; Wintermark M; Patrie JT; Rehm PK; Sheehan JP; Schiff D
    AJR Am J Roentgenol; 2019 Feb; 212(2):425-430. PubMed ID: 30422717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases.
    Du P; Liu X; Xiang R; Lv K; Chen H; Liu W; Cao A; Chen L; Wang X; Yu T; Ding J; Li W; Li J; Li Y; Yu Z; Zhu L; Liu J; Geng D
    Eur Radiol; 2023 Dec; 33(12):8925-8935. PubMed ID: 37505244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastases from NSCLC treated with stereotactic radiotherapy: prediction mismatch between two different radiomic platforms.
    Carloni G; Garibaldi C; Marvaso G; Volpe S; Zaffaroni M; Pepa M; Isaksson LJ; Colombo F; Durante S; Lo Presti G; Raimondi S; Spaggiari L; de Marinis F; Piperno G; Vigorito S; Gandini S; Cremonesi M; Positano V; Jereczek-Fossa BA
    Radiother Oncol; 2023 Jan; 178():109424. PubMed ID: 36435336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases.
    Huber PE; Hawighorst H; Fuss M; van Kaick G; Wannenmacher MF; Debus J
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1339-49. PubMed ID: 11286842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
    Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
    J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.